Ir para o conteúdo principal

Infelizmente, não oferecemos suporte total ao seu navegador. Se for possível, atualize para uma versão mais recente ou use o Mozilla Firefox, o Microsoft Edge, o Google Chrome ou o Safari 14 ou mais recente. Se não conseguir e precisar de suporte, envie seu feedback.

Gostaríamos de receber seu feedback sobre essa nova experiência.Diga-nos sua opinião

Elsevier
Publique conosco

Profile

Matt Simon

Matthew Simon

Denali Therapeutics, USA

Matt Simon is a Principal Scientist at Denali Therapeutics interested in drug delivery to the CNS and RNA based therapeutic strategies for neurodegenerative diseases. Matt received his PhD in neuroscience at Oregon Health & Science University, studying brain-CSF interactions in aging and neurodegeneration. He has been at Denali Therapeutics for 6 years, using in vivo models of neurodegeneration to investigate brain penetrant therapeutic strategies, and profile disease mechanisms and biomarkers. His current research focuses on the delivery and impact of RNA modifying therapeutics for treatment of CNS diseases.